In these large-scale, randomised controlled trials involving thousands of participants, mood disorders were not reported at rates substantially different from placebo groups
Microvascular disease and microvascular dysfunction
BALANCE Model (2027+): A longer-term demonstration program that aims to integrate GLP-1 coverage into Medicare Part D permanently, with a requirement that beneficiaries participate in lifestyle modification programs
Most programs start with training
Their counterparts Wegovy and Zepbound are prescribed for weight loss
McConnell, is that this has something to do with the fact that tirzepatides work on two gut hormones, GLP-1, which regulates blood sugar and appetite, and GIP, which secretes insulin, while semaglutides like Ozempic and Wegovy only work on the former